Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Change in Accured Expenses (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Change in Accured Expenses for 3 consecutive years, with -$1.5 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses changed N/A to -$1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $3.3 million for FY2025, N/A changed from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$1.5 million at Adagio Medical Holdings, down from -$577000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $678000.0 in Q1 2024, with the low at -$1.5 million in Q4 2025.
  • Average Change in Accured Expenses over 3 years is -$426666.7, with a median of -$434500.0 recorded in 2024.
  • Peak annual rise in Change in Accured Expenses hit 185.1% in 2025, while the deepest fall reached 185.1% in 2025.
  • Over 3 years, Change in Accured Expenses stood at -$216000.0 in 2023, then plummeted by 201.39% to -$651000.0 in 2024, then tumbled by 130.72% to -$1.5 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$1.5 million, -$577000.0, and -$651000.0 for Q4 2025, Q1 2025, and Q3 2024 respectively.